DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma

por Ettrich, Thomas J., Perkhofer, Lukas, von Wichert, Goetz, Gress, Thomas M., Michl, Patrick, Hebart, Holger F., Büchner-Steudel, Petra, Geissler, Michael, Muche, Rainer, Danner, Bettina, Kächele, Volker, Berger, Andreas W., Güthle, Melanie, Seufferlein, Thomas
Publicado 2016

Efficacy and Safety of CAP7.1 as Second-Line Treatment for Advanced Biliary Tract Cancers: Data from a Randomised Phase II Study

por Pape, Ulrich-Frank, Kasper, Stefan, Meiler, Johannes, Sinn, Marianne, Vogel, Arndt, Müller, Lothar, Burkhard, Oswald, Caca, Karel, Heeg, Steffen, Büchner-Steudel, Petra, Rodriguez-Laval, Victor, Kühl, Anja A, Arsenic, Ruza, Jansen, Holger, Treasure, Peter, Utku, Nalân
Publicado 2020

Pre-Study protocol MagPEP: a multicentre randomized controlled trial of magnesium sulphate in the prevention of post-ERCP pancreatitis

por Fluhr, Gabriele, Mayerle, Julia, Weber, Eckhard, Aghdassi, Ali, Simon, Peter, Gress, Thomas, Seufferlein, Thomas, Mössner, Joachim, Stallmach, Andreas, Rösch, Thomas, Müller, Martina, Siegmund, Britta, Büchner-Steudel, Petra, Zuber-Jerger, Ina, Kantowski, Marcus, Hoffmeister, Albrecht, Rosendahl, Jonas, Linhart, Thomas, Maul, Jochen, Czakó, László, Hegyi, Péter, Kraft, Matthias, Engel, Georg, Kohlmann, Thomas, Glitsch, Anne, Pickartz, Tilman, Budde, Christoph, Nitsche, Claudia, Storck, Kirsten, Lerch, Markus M
Publicado 2013